IPHA Innate Pharma
- 2.250
- 0.0000.00%
Innate Pharma News
S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Analysis
Price Target
No Data
No Data